Home LiteratureArticle Details
PMID: 3049374 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Strain variation in phagocytosis of Cryptococcus neoformans: dissociation of susceptibility to phagocytosis from activation and binding of opsonic fragments of C3.

Infection and immunity ·Vol. 56 ·No. 11 ·1988-11-00 ·Pages 2794-800

Kozel TR, Pfrommer GS, Guerlain AS, Highison BA, Highison GJ

Abstract

Phagocytosis of Cryptococcus neoformans is markedly influenced by the presence of a polysaccharide capsule. We examined activation and binding of C3 fragments to eight isolates of C. neoformans. All isolates were shown to have capsules by light and electron microscopy. These strains differed in susceptibility to phagocytosis by neutrophils. Yeast cells were opsonized by incubation in normal human serum. Five strains were resistant to ingestion, two strains showed intermediate levels of resistance to ingestion, and one strain was quite sensitive to phagocytosis. Yeast cells opsonized with heat-inactivated serum (56 degrees C for 30 min) neither attached nor were ingested by neutrophils. A quantitative estimate of the amount of C3 bound to the yeast cells was determined by use of normal human serum containing 125I-labeled C3. The results showed approximately 5 X 10(6) to 10 X 10(6) C3 molecules per yeast cell regardless of whether the yeast cells were sensitive or resistant to phagocytosis. Bound C3 was eluted from the yeast cells by treatment with 0.1 M NH2OH (pH 10), and the eluted fragments were examined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis under reducing conditions. Results of this analysis showed that little of the C3 was in the form of C3b, and there was substantial decay to iC3b, the inactive decay product of C3b. This pattern of decay was similar with all strains. Immunoelectron microscopy was used to assess the ultrastructural location of the C3 fragments bound to the yeast cells. C3 fragments were bound to the perimeter of the capsule regardless of whether the isolate was sensitive or resistant to phagocytosis. Thus, phagocytosis-sensitive and phagocytosis-resistant isolates were similar with regard to the amount, molecular form, and ultrastructural location of C3 fragments bound to the cryptococcal capsule. These results further indicate that activation of the complement cascade is necessary but not sufficient for phagocytosis of the yeast cell.

MeSH Terms
Complement Activation Complement C3/physiology Cryptococcus/immunology Cryptococcus neoformans/immunology,ultrastructure Humans Neutrophils/physiology Phagocytosis Species Specificity
Chemicals
Complement C3
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Kozel T R
Department of Microbiology, School of Medicine, University of Nevada-Reno 89557.
Pfrommer G S
Guerlain A S
Highison B A
Highison G J
References (26)
26 references, click to expand
  1. Control of the amplification convertase of complement by the plasma protein beta1H.
    Proc Natl Acad Sci U S A. 1976 Sep;73(9):3268-72 PMID: 1067618
  2. Interaction between the third complement protein and cell surface macromolecules.
    Proc Natl Acad Sci U S A. 1977 Jul;74(7):2701-5 PMID: 268620
  3. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.
    Biochem Biophys Res Commun. 1978 Feb 28;80(4):849-57 PMID: 637870
  4. Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells.
    Proc Natl Acad Sci U S A. 1978 May;75(5):2416-20 PMID: 276881
  5. Cryptic peptidoglycan and the antiphagocytic effect of the Staphylococcus aureus capsule: model for the antiphagocytic effect of bacterial cell surface polymers.
    Infect Immun. 1979 Feb;23(2):502-8 PMID: 422250
  6. Evidence for an ester linkage between the labile binding site of C3b and receptive surfaces.
    J Immunol. 1979 Sep;123(3):1388-94 PMID: 38283
  7. Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization.
    Infect Immun. 1979 Aug;25(2):603-9 PMID: 385502
  8. Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes.
    J Clin Invest. 1980 Jan;65(1):82-94 PMID: 6985617
  9. Immunofluorescence studies of reactions at the Cryptococcal capsule.
    J Infect Dis. 1968 Apr;118(2):215-29 PMID: 4870973
  10. Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro.
    J Infect Dis. 1972 Apr;125(4):367-76 PMID: 4553080
  11. In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformans.
    Infect Immun. 1972 Apr;5(4):491-8 PMID: 4564677
  12. The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection.
    J Immunol. 1974 Jun;112(6):2260-70 PMID: 4596700
  13. Single-step separation of red blood cells. Granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque.
    J Immunol Methods. 1974 Aug;5(3):249-52 PMID: 4427075
  14. Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis.
    Infect Immun. 1976 Jul;14(1):62-7 PMID: 780279
  15. Localization of the third component of complement on the cell wall of encapsulated Staphylococcus aureus M: implications for the mechanism of resistance to phagocytosis.
    Infect Immun. 1979 Dec;26(3):1159-63 PMID: 393630
  16. Phagocytosis of microorganisms.
    Rev Infect Dis. 1982 Jan-Feb;4(1):104-23 PMID: 6122253
  17. Opsonic requirements for the uptake of Cryptococcus neoformans by human polymorphonuclear leukocytes and monocytes.
    J Infect Dis. 1982 Jun;145(6):870-4 PMID: 7045251
  18. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.
    J Immunol. 1982 Oct;129(4):1681-7 PMID: 7108223
  19. Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification procedures.
    J Immunol. 1983 Jan;130(1):370-5 PMID: 6847888
  20. Localization on encapsulated Cryptococcus neoformans of serum components opsonic for phagocytosis by macrophages and neutrophils.
    Infect Immun. 1984 Feb;43(2):574-9 PMID: 6363293
  21. The chemistry and biology of complement receptors.
    Springer Semin Immunopathol. 1984;7(2-3):221-49 PMID: 6238434
  22. Human neutrophils increase expression of C3bi as well as C3b receptors upon activation.
    J Clin Invest. 1984 Nov;74(5):1566-71 PMID: 6209300
  23. Capsule of Escherichia coli K29: ultrastructural preservation and immunoelectron microscopy.
    J Bacteriol. 1985 Jun;162(3):985-91 PMID: 3888968
  24. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.
    J Exp Med. 1985 Jun 1;161(6):1414-31 PMID: 2409200
  25. Serotypic variations among virulent pneumococci in deposition and degradation of covalently bound C3b: implications for phagocytosis and antibody production.
    J Infect Dis. 1986 Apr;153(4):682-93 PMID: 3950449
  26. Activation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast.
    Infect Immun. 1986 Apr;52(1):1-5 PMID: 3514450
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1988-11-00
Pages
2794-800
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC259652
Subset
IM
Grants
PHS HHS · A114209 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com